Tag Archive for: Jazz

partnership

Jazz Pharmaceuticals licences KRAS blocker from Redx Pharma

Jazz Pharmaceuticals plc has entered an agreement with Redx Pharma to acquire commercialisation rights to Redx KRAS blockers, which include G12D selective and pan-KRAS molecules.

Read more